Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Piyadasa (Winnipeg, Canada), M. Hemshekhar (Winnipeg, Canada), A. Altieri (Winnipeg, Canada), S. Basu (Winnipeg, Canada), A. Van Der Does (Leiden, Netherlands), A. Halayko (Winnipeg, Canada), P. Hiemstra (Leiden, Netherlands), N. Mookherjee (Winnipeg, Canada). Activity of an innate defence regulator peptide to alleviate airway inflammation is mitigated by disruption of its central hydrophobic region. 1104

Member's Comments

No comment yet.

Related content which might interest you: Activation of proteolytic mechanisms in response to inflammatory stimuli: a possible role in the development of the aleolocapillary barrier damage Source: Eur Respir J 2003; 22: Suppl. 45, 458s Year: 2003 Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Apolipoprotein A1 regulate innate immune response and tight junction formation in the airway epithelium to promote the resolution of allergic airway inflammation Source: Annual Congress 2012 - Mechanisms of asthma Year: 2012 Cathelicidin modulates the epithelial innate immune response to endotoxin Source: Annual Congress 2008 - Best of lung epithelial cells 2008 Year: 2008 Immunology and defence mechanism of the developing lung Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60 Year: 2006 Gut microbial modulation attenuates emphysema development by suppressing inflammation and apoptosis Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Oral presentation: Inhibition of innate host defense in airway epithelial cells by cigarette smoke in an in vitro infection model caused by suppression of NF-kB activation Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B. Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 The role of innate immune cells in inflammation Source: International Congress 2015 – Resolving inflammation Year: 2015 The role of ACN9 in the inflammatory response in the airway Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 PTX3 as a component of innate immunity in the role of captopril in acute lung injury induced by bacterial endotoxin Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 LSC 2010 Abstract: Inhibition of innate host defense in airway epithelial cells by cigarette smoke in an in vitro infection model caused by suppression of NF-κB activation Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease Year: 2010 Dysregulation of host defence peptides by environmental challenge: Can we mitigate the pathophysiology? Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma Year: 2019 Signs of MICA as an innate immune molecule potentially involved in vascular remodelling in patients with pulmonary hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 The airway microbiota: a key regulator of homeostasis and fibrosis Source: International Congress 2016 – Microbiome in health and in disease Year: 2016 Extracellular vesicles are key intercellular mediators in the development of immune dysfunction to allergens in the airway Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010